Psychiatry News

Children living with parents with mental illness were four times as likely to be placed in out-of-home care than their peers, according to findings from a Swedish study published in Pediatrics.

Long-acting injectable antipsychotic medications reduced hospital readmission rates among patients with schizophrenia and schizoaffective disorder compared with oral antipsychotic medications, according to a recent study.

Patients who are hospitalized with stroke-like symptoms, but do not experience a stroke, may yet develop PTSD at a higher rate than patients who actually had a stroke, a speaker reported.

The FDA has granted breakthrough therapy designation to latozinemab, an investigational therapeutic designed to block sortilin and elevate progranulin to treat frontotemporal dementia with a progranulin gene mutation.

The COVID-19 pandemic reduced children’s readiness for kindergarten, researchers reported in JAMA Pediatrics.

Wölfflin nodules are light-colored, peripheral iris nodules that are found in 10% of healthy individuals and almost exclusively in patients with light irides.

For those with either acute ischemic stroke or intracerebral hemorrhage, risk of dementia was three times higher after the first year and remained elevated as many as 20 years after, a speaker said at the International Stroke Conference.

erious psychological distress among adults rose over the course of the COVID-19 pandemic, their access to outpatient mental health care decreased, researchers found.

The American Psychiatric Association has selected Marketa Wills, MD, MBA, as its new CEO and medical director, effective June 1.

Silo Pharma will advance a portfolio of four drugs in its 2024 clinical pipeline, targeting conditions related to mental health, chronic pain and neurology.